Ron Finklestien
This Was the Biggest Surprise to Come Out of Walmart's Earnings. Should You Buy the Stock Hand Over Fist?
Walmart (NYSE: WMT) made waves last week when it reported better-than-expected earnings results, and the stock is up around 10%. There is a lot ...
Should You Invest in Nice (NICE) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports ...
Builders FirstSource (BLDR) Stock Up 48% in a Year: Here’s Why
Builders FirstSource, Inc.’s BLDR shares gained 48% in the past year compared with the Zacks Building Products – Retail industry’s 9.7% increase. It is ...
Here's My Top Cybersecurity Stock (and It's Not Even Close)
While artificial intelligence (AI) is attracting investors’ attention, there’s another massive trend they should be aware of: cybersecurity. Bad actors have never had more ...
Is Skechers (SKX) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports ...
S&P 500 Snapshot: See-Saw Week Ends with Minor Gains
The S&P 500 see-sawed this week, ending with only minor gains (+0.03%) from a week ago. The index is currently up 11.85% year to ...
1 Stock-Split Artificial Intelligence (AI) Stock Up 1,080% in 4 Years to Buy Now, According to Wall Street
Nvidia (NASDAQ: NVDA) shares advanced 1,080% during the last four years, meaning $10,000 invested in the semiconductor company in May 2020 would now be ...
Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Novartis NVS announced results from the six-month, double-blind trial period of the late-stage APPEAR-C3G study of Fabhalta. Fabhalta, an oral Factor B inhibitor of ...
